Flc Capital Advisors Abb Vie Inc. Transaction History

Flc Capital Advisors

$430 Million
Q3 2024

A detailed history of Flc Capital Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Flc Capital Advisors holds 4,772 shares of ABBV stock, worth $858,960. This represents 0.22% of its overall portfolio holdings.

Number of Shares

4,772

Previous 5,717 16.53%

Holding current value

$858,960

Previous $980,000 3.88%

% of portfolio

0.22%

Previous 0.24%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$163.84 - $199.33 $154,828 - $188,366	-945 Reduced 16.53%	4,772 $942,000
Q2 2024 Jul 15, 2024	SELL	$154.79 - $180.76 $160,981 - $187,990	-1,040 Reduced 15.39%	5,717 $980,000
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $21,575 - $24,583	-135 Reduced 1.96%	6,757 $1.23 Million
Q4 2023 Jan 18, 2024	SELL	$137.6 - $154.97 $8,256 - $9,298	-60 Reduced 0.86%	6,892 $1.07 Million
Q3 2023 Jan 18, 2024	SELL	$133.59 - $154.65 $10,687 - $12,372	-80 Reduced 1.14%	6,952 $1.04 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $132,510 - $164,900	-1,000 Reduced 12.45%	7,032 $947,000
Q1 2023 Apr 26, 2023	SELL	$144.61 - $166.54 $331,735 - $382,042	-2,294 Reduced 22.22%	8,032 $1.28 Million
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $89,901 - $107,815	-650 Reduced 5.92%	10,326 $1.67 Million
Q3 2022 Oct 14, 2022	SELL	$134.21 - $153.93 $196,617 - $225,507	-1,465 Reduced 11.78%	10,976 $1.47 Million
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $46,193 - $57,312	-350 Reduced 2.74%	12,441 $2.02 Million
Q4 2021 Jan 26, 2022	SELL	$107.43 - $135.93 $66,391 - $84,004	-618 Reduced 4.61%	12,791 $1.73 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $8,416 - $9,376	80 Added 0.6%	13,409 $1.51 Million
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $10,230 - $11,262	100 Added 0.76%	13,329 $1.44 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $69,140 - $93,347	859 Added 6.94%	13,229 $1.42 Million
Q3 2020 Oct 23, 2020	BUY	$85.91 - $100.83 $124,655 - $146,304	1,451 Added 13.29%	12,370 $1.04 Million
Q2 2020 Jul 10, 2020	BUY	$73.37 - $98.18 $111,008 - $148,546	1,513 Added 16.09%	10,919 $1.08 Million
Q1 2020 Apr 09, 2020	BUY	$64.5 - $97.79 $237,360 - $359,867	3,680 Added 64.27%	9,406 $707,000
Q4 2019 Jan 13, 2020	SELL	$72.13 - $90.25 $18,825 - $23,555	-261 Reduced 4.36%	5,726 $507,000
Q3 2019 Oct 29, 2019	SELL	$62.98 - $75.72 $45,597 - $54,821	-724 Reduced 10.79%	5,987 $453,000
Q2 2019 Aug 05, 2019	BUY	$65.7 - $83.98 $64,977 - $83,056	989 Added 17.28%	6,711 $478,000
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $59,860 - $70,453	776 Added 15.69%	5,722 $461,000
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $385,046 - $474,865	4,946 New	4,946 $456,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flc Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Flc Capital Advisors with notifications on news.

Account

Flc Capital Advisors Abb Vie Inc. Transaction History